Chacko Jacob
Insider CIK 1608936 · RXDX Chief Financial Officer · TPTX Director · FDMT Director · ORIC President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-06-17 | 2026-06-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 112,500 | — | $0 | 112,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 675,000 | — | $0 | 675,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2025-12-16 | 2025-12-17 | 33,374 | $9.06 | $302.4K | 581,711 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-15 | 2025-12-17 | 28,333 | — | $0 | 28,334 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-15 | 2025-12-17 | 22,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-12-15 | 2025-12-17 | 33,333 | — | $0 | 66,667 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-12-15 | 2025-12-17 | 83,666 | — | $0 | 615,085 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2025-10-06 | 2025-10-08 | 37,461 | $12.32 | $461.5K | 531,419 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2025-10-01 | 2025-10-02 | 53,001 | $12.05 | $638.7K | 568,880 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2025-09-30 | 2025-10-02 | 34,538 | $12.01 | $414.8K | 621,881 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2025-09-22 | 2025-09-24 | 125,000 | $10.80 | $1.35M | 656,419 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-06-17 | 2025-06-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2024-12-16 | 2024-12-17 | 24,660 | $8.28 | $204.2K | 778,648 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-15 | 2024-12-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-15 | 2024-12-17 | 28,333 | — | $0 | 56,667 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-15 | 2024-12-17 | 16,667 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2024-12-15 | 2024-12-17 | 67,000 | — | $0 | 803,308 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2024-05-21 | 2024-05-23 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2024-03-06 | 2024-03-08 | 40,000 | $16.21 | $648.4K | 728,544 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2024-02-07 | 2024-02-08 | 26,042 | $12.30 | $320.3K | 768,544 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2024-02-06 | 2024-02-08 | 13,958 | $12.12 | $169.2K | 794,586 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-03 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-03 | 510,000 | — | $0 | 510,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2023-12-15 | 2023-12-19 | 16,667 | — | $0 | 16,667 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2023-12-15 | 2023-12-19 | 22,000 | — | $0 | 44,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2023-12-15 | 2023-12-19 | 14,539 | $8.58 | $124.7K | 808,544 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2023-12-15 | 2023-12-19 | 38,667 | — | $0 | 823,083 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2023-07-11 | 2023-07-11 | 5,156 | $8.01 | $41.3K | 780,652 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2023-07-10 | 2023-07-11 | 10,508 | $8.01 | $84.2K | 785,808 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2023-07-05 | 2023-07-07 | 4,336 | $8.01 | $34.7K | 796,316 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2023-06-26 | 2023-06-28 | 20,000 | $8.03 | $160.6K | 800,652 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | A Award deriv | 2023-05-23 | 2023-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2023-04-21 | 2023-04-25 | 5,000 | — | $0 | 32,500 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-04-21 | 2023-04-25 | 5,000 | $20.05 | $100.3K | 0 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2023-04-21 | 2023-04-25 | 5,000 | $9.41 | $47.0K | 5,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 66,000 | — | $0 | 66,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2022-12-15 | 2023-02-17 | 6,137 | $3.07 | $18.8K | 816,652 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2022-12-15 | 2022-12-16 | 16,666 | — | $0 | 33,334 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2022-12-15 | 2022-12-16 | 16,666 | — | $0 | 822,789 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2022-12-15 | 2022-12-16 | 5,764 | $3.25 | $18.7K | 817,025 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-07-20 | 2022-07-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-07-20 | 2022-07-21 | 280,000 | — | $0 | 280,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | D To issuer deriv | 2022-07-20 | 2022-07-21 | 280,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-07-20 | 2022-07-21 | 437,500 | — | $0 | 437,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | D To issuer deriv | 2022-07-20 | 2022-07-21 | 300,000 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | D To issuer deriv | 2022-07-20 | 2022-07-21 | 437,500 | — | $0 | 0 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2022-05-23 | 2022-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | P Buy | 2022-05-13 | 2022-05-13 | 76,072 | $2.82 | $214.5K | 802,652 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | P Buy | 2022-05-12 | 2022-05-13 | 69,354 | $2.75 | $190.7K | 726,580 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | P Buy | 2022-05-11 | 2022-05-13 | 304,574 | $2.90 | $883.3K | 657,226 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | P Buy | 2022-03-25 | 2022-03-25 | 50,000 | $4.54 | $227.0K | 352,652 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | P Buy | 2022-03-24 | 2022-03-25 | 42,873 | $5.03 | $215.7K | 302,652 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | P Buy | 2022-03-23 | 2022-03-25 | 257,127 | $4.98 | $1.28M | 259,779 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-02-01 | 2022-02-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-02-01 | 2022-02-02 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 3,736 | $25.06 | $93.6K | 2,652 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 4,420 | $25.05 | $110.7K | 6,388 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-13 | 2021-09-14 | 2,801 | $25.02 | $70.1K | 10,808 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-10 | 2021-09-14 | 2,942 | $25.08 | $73.8K | 13,609 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-08 | 2021-09-09 | 200 | $25.04 | $5.0K | 16,551 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-07 | 2021-09-09 | 5,981 | $25.11 | $150.2K | 16,751 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-27 | 2021-05-28 | 400 | $25.07 | $10.0K | 22,732 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-24 | 2021-05-24 | 12 | $25.00 | $300 | 23,132 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-21 | 2021-05-24 | 4,790 | $25.20 | $120.7K | 23,144 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-20 | 2021-05-24 | 2,468 | $25.07 | $61.9K | 27,934 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-18 | 2021-05-18 | 11,132 | $25.37 | $282.4K | 30,602 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-18 | 2021-05-18 | 200 | $26.03 | $5.2K | 30,402 | SEC↗ |
| FDMT 4D Molecular Therapeutics | A Award deriv | 2021-05-17 | 2021-05-19 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-17 | 2021-05-18 | 2,550 | $25.05 | $63.9K | 41,734 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-14 | 2021-05-18 | 13,896 | $25.36 | $352.4K | 44,284 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-13 | 2021-05-13 | 730 | $25.04 | $18.3K | 58,180 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 400 | $25.02 | $10.0K | 58,910 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 1,090 | $25.22 | $27.5K | 59,310 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-04-30 | 2021-04-30 | 600 | $25.24 | $15.1K | 60,400 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-04-28 | 2021-04-30 | 700 | $25.06 | $17.5K | 61,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 800 | $25.09 | $20.1K | 61,700 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2021-02-01 | 2021-02-02 | 280,000 | — | $0 | 280,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-06-15 | 2020-06-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 62,500 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion | 2020-04-28 | 2020-04-28 | 62,500 | — | $0 | 62,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2020-04-23 | 2020-04-27 | 437,500 | — | $0 | 437,500 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2019-04-22 | 2019-04-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer deriv | 2018-02-08 | 2018-02-12 | 25,200 | — | $0 | 0 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer deriv | 2018-02-08 | 2018-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer deriv | 2018-02-08 | 2018-02-12 | 250,000 | — | $0 | 0 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer | 2018-02-08 | 2018-02-12 | 70,572 | $27.00 | $1.91M | 0 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2018-01-05 | 2018-01-05 | 4,400 | — | $0 | 70,572 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2017-12-22 | 2017-12-22 | 23,334 | — | $0 | 66,172 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2017-01-05 | 2017-01-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RXDX Ignyta, Inc. | P Buy | 2016-03-17 | 2016-03-21 | 10,000 | $5.64 | $56.4K | 42,838 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2016-01-07 | 2016-01-11 | 26,400 | — | $0 | 32,838 | SEC↗ |
| RXDX Ignyta, Inc. | P Buy | 2015-12-16 | 2015-12-17 | 1,500 | $12.00 | $18.0K | 6,438 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2015-08-20 | 2015-08-21 | 1,500 | $12.40 | $18.6K | 4,938 | SEC↗ |
| RXDX Ignyta, Inc. | P Buy | 2015-08-20 | 2015-08-27 | 1,500 | $12.40 | $18.6K | 4,938 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2015-01-08 | 2015-01-09 | 25,200 | — | $0 | 25,200 | SEC↗ |
| RXDX Ignyta, Inc. | P Buy | 2014-11-24 | 2014-11-24 | 930 | $6.50 | $6.0K | 3,438 | SEC↗ |
| RXDX Ignyta, Inc. | P Buy | 2014-11-21 | 2014-11-24 | 668 | $6.40 | $4.3K | 2,508 | SEC↗ |
| RXDX Ignyta, Inc. | P Buy | 2014-08-19 | 2014-08-19 | 1,540 | $7.53 | $11.6K | 1,840 | SEC↗ |
| RXDX Ignyta, Inc. | P Buy | 2014-08-15 | 2014-08-19 | 300 | $7.50 | $2.3K | 300 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2014-05-30 | 2014-05-30 | 250,000 | — | $0 | 250,000 | SEC↗ |